Literature DB >> 23999392

Production and biomedical applications of virus-like particles derived from polyomaviruses.

Erik A Teunissen1, Markus de Raad1, Enrico Mastrobattista2.   

Abstract

Virus-like particles (VLPs), aggregates of capsid proteins devoid of viral genetic material, show great promise in the fields of vaccine development and gene therapy. These particles spontaneously self-assemble after heterologous expression of viral structural proteins. This review will focus on the use of virus-like particles derived from polyomavirus capsid proteins. Since their first recombinant production 27 years ago these particles have been investigated for a myriad of biomedical applications. These virus-like particles are safe, easy to produce, can be loaded with a broad range of diverse cargoes and can be tailored for specific delivery or epitope presentation. We will highlight the structural characteristics of polyomavirus-derived VLPs and give an overview of their applications in diagnostics, vaccine development and gene delivery.
© 2013. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AFFFF; APyV; BK virus; BKPyV; CTL; ChPyV; DC; DHFR; DIVA; DTT; E. coli; EDTA; EGFP; EGTA; ER; Escherichia coli; FPyV; GCV; GHPyV; GRAS; GST; Gene delivery; Gene therapy; HPV; HaPyV; JC virus; JCPyV; LCMV; LPyV; MALS; MCC; MCPyV; MPtV; MPyV; Merkel cell carcinoma; Merkel cell polyomavirus; NLS; NP; NTA; OVA; PBS; PLP; PNA; PSA; PTX; PUUV; Polyomavirus; Pseudovirion; Puumala hantavirus; PyV; S. cerevisiae; SR101; SV40; Saccharomyces cerevisiae; Sf; Spodoptera frugiperda; TEM; VLP; Vaccine; Virus-like particle; aa; amino acid; asymmetrical-flow field flow fractionation; avian polyomavirus; base pair; beta-lymphotropic polyomavirus; bp; chimpanzee polyomavirus; cytotoxic T lymphocyte; dendritic cell; differentiate infected from vaccinated animals; dihydrofolate reductase; dithiothreitol; double-stranded DNA; dsDNA; endoplasmic reticulum; enhanced green fluorescent protein; ethylene glycol tetraacetic acid; ethylenediaminetetraacetic acid; finch polyomavirus; ganciclovir; generally recognized as safe; glutathione S-transferase; goose hemorrhagic polyomavirus; hEGF; hamster polyomavirus; human epidermal growth factor; human papillomavirus; lymphocytic choriomeningitis virus; multiple-angle light scattering; murine pneumotropic virus; murine polyomavirus; nitrilotriacetic acid; nuclear localization signal; nucleocapsid protein; ovalbumin; paclitaxel; peptide nucleic acids; phosphate buffered saline; polyoma-like particle; polyomavirus; prostate specific antigen; simian virus 40; sulforhodamine 101; transmission electron microscopy; virus-like particle

Mesh:

Substances:

Year:  2013        PMID: 23999392     DOI: 10.1016/j.jconrel.2013.08.026

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  16 in total

1.  Assembly and Purification of Polyomavirus-Like Particles from Plants.

Authors:  Emeline V B Catrice; Frank Sainsbury
Journal:  Mol Biotechnol       Date:  2015-10       Impact factor: 2.695

2.  Adenovirus Dodecahedron, a VLP, Can be Purified by Size Exclusion Chromatography Instead of Time-Consuming Sucrose Density Gradient Centrifugation.

Authors:  I Szurgot; M Jedynak; M Podsiadla-Bialoskorska; Jan Piwowarski; E Szolajska; J Chroboczek
Journal:  Mol Biotechnol       Date:  2015-06       Impact factor: 2.695

3.  Protein Nanoparticles as Multifunctional Biocatalysts and Health Assessment Sensors.

Authors:  Maryam Raeeszadeh-Sarmazdeh; Emily Hartzell; J Vincent Price; Wilfred Chen
Journal:  Curr Opin Chem Eng       Date:  2016-09-04       Impact factor: 5.163

4.  Inhibition of human diffuse large B-cell lymphoma growth by JC polyomavirus-like particles delivering a suicide gene.

Authors:  Chun-Nun Chao; Yih-Leh Huang; Mien-Chun Lin; Chiung-Yao Fang; Cheng-Huang Shen; Pei-Lain Chen; Meilin Wang; Deching Chang; Chih-En Tseng
Journal:  J Transl Med       Date:  2015-01-27       Impact factor: 5.531

Review 5.  In Vitro and In Vivo Models for the Study of Human Polyomavirus Infection.

Authors:  Heidi Barth; Morgane Solis; Wallys Kack-Kack; Eric Soulier; Aurélie Velay; Samira Fafi-Kremer
Journal:  Viruses       Date:  2016-10-22       Impact factor: 5.048

Review 6.  Biology of the BKPyV: An Update.

Authors:  Francois Helle; Etienne Brochot; Lynda Handala; Elodie Martin; Sandrine Castelain; Catherine Francois; Gilles Duverlie
Journal:  Viruses       Date:  2017-11-03       Impact factor: 5.048

Review 7.  BK Polyomavirus Nephropathy in Kidney Transplantation: Balancing Rejection and Infection.

Authors:  Chia-Lin Shen; Bo-Sheng Wu; Tse-Jen Lien; An-Hang Yang; Chih-Yu Yang
Journal:  Viruses       Date:  2021-03-16       Impact factor: 5.048

8.  Production of recombinant VP1-derived virus-like particles from novel human polyomaviruses in yeast.

Authors:  Milda Norkiene; Jomante Stonyte; Danguole Ziogiene; Egle Mazeike; Kestutis Sasnauskas; Alma Gedvilaite
Journal:  BMC Biotechnol       Date:  2015-08-04       Impact factor: 2.563

9.  Evaluation of Trichodysplasia Spinulosa-Associated Polyomavirus Capsid Protein as a New Carrier for Construction of Chimeric Virus-Like Particles Harboring Foreign Epitopes.

Authors:  Alma Gedvilaite; Indre Kucinskaite-Kodze; Rita Lasickiene; Albertas Timinskas; Ausra Vaitiekaite; Danguole Ziogiene; Aurelija Zvirbliene
Journal:  Viruses       Date:  2015-07-29       Impact factor: 5.048

10.  Scaffolded Antigens in Yeast Cell Particle Vaccines Provide Protection against Systemic Polyoma Virus Infection.

Authors:  Donald J Tipper; Eva Szomolanyi-Tsuda
Journal:  J Immunol Res       Date:  2016-04-26       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.